CXCL12 and neoplasm: The chemokine CXCL12-CXCR4/CXCR7 axis as a mechanism of tumor microenvironment and immune resistance in glioblastoma [31], bladder cancer [32], colorectal cancer [33] and gastrointestinal malignancies [34].